01 1Allergan Inc.
02 2Gowling WLG (Canada) LLP
01 12713254
02 22745084
01 3ULIPRISTAL ACETATE
01 3TABLET
01 12029-01-28
02 22029-12-08
Patent Expiration Date : 2029-01-28
Date Granted : 2014-10-07
Brand Name : FIBRISTAL
Patent Number : 2713254
Filing Date : 2009-01-28
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-01-28
Date Granted : 2014-10-07
Patent Expiration Date : 2029-12-08
Date Granted : 2014-11-18
Brand Name : FIBRISTAL
Patent Number : 2745084
Filing Date : 2009-12-08
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-12-08
Date Granted : 2014-11-18
Patent Expiration Date : 2029-12-08
Date Granted : 2014-11-18
Brand Name : ELLA
Patent Number : 2745084
Filing Date : 2009-12-08
Strength per Unit : 30 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-12-08
Date Granted : 2014-11-18
LOOKING FOR A SUPPLIER?